Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

DMSO-PDT of BCC - A 6 Year Follow Up

This study has been completed.
Sponsor:
Information provided by:
Norwegian University of Science and Technology
ClinicalTrials.gov Identifier:
NCT00218829
First received: September 20, 2005
Last updated: May 16, 2006
Last verified: September 2005
  Purpose

The purpose of this study is to registrate long time clinical and histological treatment response of BCC lesions treated with one or two procedures of DMSO-PDT.


Condition
Carcinoma, Basal Cell

Study Type: Observational
Study Design: Time Perspective: Longitudinal
Official Title: Dimethylsulphoxide-Supported Photodynamic Therapy of Basal Cell Carcinoma Combined With Curretage - A 6 Year Clinical and Histological Evaluation.

Further study details as provided by Norwegian University of Science and Technology:

Estimated Enrollment: 48
Study Start Date: September 1997
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • histological verified bcc.
  • one or two PDT treatments with treatment interval no longer than two weeks.
  • lesion complete response three months after therapy.

Exclusion Criteria:

  • pregnant.
  • Gorlin's syndrome.
  • morpheaform or pigmented bcc.
  • histology older than one year.
  • tumour infiltration more than four mm.
  • previous PDT treated lesions.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00218829

Sponsors and Collaborators
Norwegian University of Science and Technology
Investigators
Principal Investigator: Eidi Christensen, MD St. Olav University Hospital, Trondheim
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00218829     History of Changes
Other Study ID Numbers: EC-002
Study First Received: September 20, 2005
Last Updated: May 16, 2006
Health Authority: Norway: Norwegian Social Science Data Services

Keywords provided by Norwegian University of Science and Technology:
Photodynamic treatment
Basal cell carcinoma
DMSO

Additional relevant MeSH terms:
Carcinoma
Carcinoma, Basal Cell
Neoplasms
Neoplasms by Histologic Type
Neoplasms, Basal Cell
Neoplasms, Glandular and Epithelial

ClinicalTrials.gov processed this record on November 25, 2014